Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

This article is part of the supplement: B cells in autoimmune diseases: Part 1

Highly Accessed Review

Rationale of anti-CD19 immunotherapy: an option to target autoreactive plasma cells in autoimmunity

Henrik E Mei*, Stefanie Schmidt and Thomas Dörner

Arthritis Research & Therapy 2012, 14(Suppl 5):S1  doi:10.1186/ar3909


  • Last 30 days: 198 accesses
  • Last 365 days: 3175 accesses
  • All time: 5025 accesses